Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity of a Fractional Adult Dose of the Malaria Vaccine R21/Matrix-M - A Noninferiority Trial

NCT07194668 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT07194668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07194668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity of a Fractional Adult Dose of the Malaria Vaccine R21/Matrix-M - A Noninferiority Trial
Lead sponsor
University of Oxford
Phase
Phase 4
Overall status
Not yet recruiting
Start date
August 15, 2026
Completion date
December 31, 2026
Enrollment
375 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, plasmodium falciparum malaria, vaccine reaction